Characterization, molecular modeling and pharmacology of some 2́-hydroxychalcone derivatives as SARS-CoV-2 inhibitor

T. Acter, N. Uddin, J. Das, A. Akhter, T.R. Choudhury, S. Kim, Evolution of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) as Coronavirus Disease 2019 (COVID-19) Pandemic: A Global Health Emergency, Sci. Total Environ. (2020) 138996. Barnard, 1993, Antiherpesvirus Activity and Mode of Action of SP-303, a Novel Plant Flavonoid, Chemotherapy, 39, 203, 10.1159/000239127 De Meyer, 1991, 4'-Hydroxy-3-methoxyflavones With Potent Antipicornavirus Activity, J. Med. Chem., 34, 736, 10.1021/jm00106a039 Awasthi, 2009, Potent antimalarial activity of newly synthesized substituted chalcone analogs in vitro, Med. Chem. Res., 18, 407, 10.1007/s00044-008-9137-9 Lim, 2007, In-vitro antimalarial activity of flavonoids and chalcones, Bull. Korean Chem. Soc., 28, 2495, 10.5012/bkcs.2007.28.12.2495 Straub, 1995, Epoxidation of α, β-unsaturated ketones with sodium perborate, Tetrahedron Lett., 36, 663, 10.1016/0040-4039(94)02346-D T. Tran, H. Park, H.P. Kim, G.F. Ecker, K. Thai, Inhibitory activity of prostaglandin E2 production by the synthetic 2́-hydroxychalcone analogues: Synthesis and SAR study, Bioorg. Med. Chem. Lett. 19 (2009) 1650–1655. Mahapatra, 2015, Chalcone scaffolds as anti-infective agents: structural and molecular target perspectives, Eur. J. Med. Chem., 101, 496, 10.1016/j.ejmech.2015.06.052 Jo, 2019, Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors, Chem. Biol. Drug Des., 94, 2023, 10.1111/cbdd.13604 Dao, 2011, Chalcones as novel influenza A (H1N1) neuraminidase inhibitors from Glycyrrhiza inflata, Bioorg. Med. Chem. Lett., 21, 294, 10.1016/j.bmcl.2010.11.016 Lin, 2005, Anti-SARS coronavirus 3Clike protease effects of Isatis indigotica root and plant derived phenolic compounds, Antiviral Res., 68, 36, 10.1016/j.antiviral.2005.07.002 Patil, 2019, Exploration of (hetero)aryl derived thienylchalcones for antiviral and anticancer activities, Med. Chem., 15, 150, 10.2174/1573406414666180524074648 Park, 2016, Chalcones isolated from Angelica keiskei inhibit cysteine proteases of SARS-CoV, J. Enzyme Inhib. Med. Chem., 31, 23, 10.3109/14756366.2014.1003215 Gleeson, 2009, QM/MM Calculations in Drug Discovery: A Useful Method for Studying Binding Phenomena?, J. Chem. Inf. Model., 49, 670, 10.1021/ci800419j M.J. Frisch, G.W. Trucks, H.B. Schlegel, G.E. Scuseria, M.A. Robb, J.R. Cheeseman, G. Scalmani, V. Barone, G.A. Petersson, H. Nakatsuji, Gaussian 16. Revis. A 3 (2016). Becke, 1988, Density-functional exchange-energy approximation with correct asymptotic behavior, Phys. Rev. A, 38, 3098, 10.1103/PhysRevA.38.3098 Lee, 1988, Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density, Phys. Rev. B, 37, 785, 10.1103/PhysRevB.37.785 Ebrahimi, 2014, Spectroscopic, thermal analysis and DFT computational studies of salen-type Schiff base complexes, Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 117, 485, 10.1016/j.saa.2013.08.044 Pearson, 1995, The HSAB Principle — more quantitative aspects, Inorg. Chim. Acta, 240, 93, 10.1016/0020-1693(95)04648-8 Azam, 2018, NSAIDs as potential treatment option for preventing amyloid β toxicity in Alzheimer’s disease: an investigation by docking, molecular dynamics, and DFT studies, J. Biomol. Struct. Dyn., 36, 2099, 10.1080/07391102.2017.1338164 Lucido, 2016, Crystal structure of aspirin-acetylated human cyclooxygenase-2: Insight in to the formation of products with reversed Stereochemistry, Biochemistry, 55, 1226, 10.1021/acs.biochem.5b01378 Guex, 1997, SWISS-MODEL and the Swiss-PdbViewer: An Environment for Comparative Protein Modeling, Electrophoresis, 18, 2714, 10.1002/elps.1150181505 W.L. Delano, The PyMOL Molecular Graphics System. De-Lano Scientific, San Carlos, CA, USA. Http://www.pymol.org. (2002). Dallakyan, 2015, Small-Molecule Library Screening by Docking with PyRx, 243 Cheng, 2012, AdmetSAR: A Comprehensive Source and Free Tool for Assessment of Chemical ADMET Properties, J. Chem. Inf. Model., 52, 3099, 10.1021/ci300367a Uddin, 2018, Synthesis, characterization, molecular modeling, antioxidant and microbial properties of some Titanium(IV) complexes of Schiff bases, J. Mol. Struct., 1166, 79, 10.1016/j.molstruc.2018.04.025 Uddin, 2018, Spectral and computational chemistry studies for the optimization of geometry of dioxomolybdenum(VI) complexes of some unsymmetrical Schiff bases as antimicrobial agent, J. Coord. Chem., 71, 3874, 10.1080/00958972.2018.1533125 M.N. Uddin, Z.A. Siddique, N. Mase, M. Uzzaman, W. Shumi, Oxotitanium(IV) complexes of some bis-unsymmetric Schiff bases: Synthesis, structural elucidation and biomedical applications, Appl. Organometal. Chem. (2019) e4876. Uzzaman, 2020, Structural Modification of Aspirin to Design a New Potential Cyclooxygenase (COX-2) Inhibitors, Silico Pharmacol., 8, 1, 10.1007/s40203-020-0053-0 Uzzaman, 2019, Optimization of Structures, Biochemical Properties of Ketorolac and Its Degradation Products Based on Computational Studies. DARU, J. Pharm. Sci., 27, 71 Uzzaman, 2019, Molecular Docking, Dynamics Simulation and ADMET Prediction of Acetaminophen and Its Modified Derivatives Based on Quantum Calculations, SN Appl. Sci., 1, 1437, 10.1007/s42452-019-1442-z Marenich, 2009, Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface Tensions, J. Phys. Chem. B, 113, 6378, 10.1021/jp810292n G.M. Morris, M. Lim-Wilby, Molecular Docking BT - Molecular Modeling of Proteins, in: Kukol (Ed.), Humana Press, Totowa, NJ, 2008, pp. 365. V.B. Zhurkin, M.Y. Tolstorukov, F. Xu, A.V. Colasanti, W.K. Olson, The Role of Hydrogen-Bonds in Drug Binding, in: DNA Conformation and Transcription; Springer US: Boston, MA, 2005, pp 18–34. Amin, 2013, P-glycoprotein Inhibition for Optimal Drug Delivery, Drug Target Insights, 7, 27, 10.4137/DTI.S12519